Hannah was 11 when she was diagnosed with acute lymphoblastic leukemia (ALL). Four years, two relapses and a 53-day hospital stay later, she is back in school.

T-cell engagers and other cellular therapies could help the immune system recognize and target lung cancer, including small cell lung cancer.

The study enrolled 25 patients with high-grade bladder cancer that had come back after earlier BCG treatment. Their median ...

Breast cancer death rates have dropped for women across the United States over the past two decades. However, they have ...

The FDA has cleared TumorSight Risk, software that uses a patient's existing breast MRI, pathology and clinical information to estimate the chance that early HR-positive, HER2-negative breast cancer ...

Patients with locally advanced breast cancer whose lymph nodes appear cancer-free after chemotherapy given before surgery may ...

Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct.

Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...

In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the ...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...

Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...